Breaking News Instant updates and real-time market news.

CSX

CSX

$54.83

-0.36 (-0.65%)

, BRK.A

Berkshire Hathaway

07:44
07/14/17
07/14
07:44
07/14/17
07:44

New CSX CEO Hunter Harrison eliminates nap breaks, WSJ says

CSX's (CSX) new CEO Hunter Harrison has eliminated the 45 minute napping breaks train conductors and engineers were allowed to take when the trains were stopped in an effort to tighten schedules and reduce downtime, the Wall Street Journal reports, citing an interview with Harrison. U.S. competitors Berkshire Hathaway's (BRK.A) BNSF Railway, Kansas City Southern (KSU), Norfolk Southern (NSC) and Union Pacific (UNP) and other small railways allow napping under certain conditions as fatigue is a common issue in the railroad industry. Reference Link

CSX

CSX

$54.83

-0.36 (-0.65%)

BRK.A

Berkshire Hathaway

KSU

Kansas City Southern

NSC

Norfolk Southern

$122.59

-0.69 (-0.56%)

UNP

Union Pacific

$108.85

-0.36 (-0.33%)

  • 19

    Jul

  • 20

    Jul

  • 21

    Jul

  • 26

    Jul

  • 21

    Aug

CSX CSX
$54.83

-0.36 (-0.65%)

05/12/17
CLVD
05/12/17
NO CHANGE
CLVD
CSX Q2 tracking below consensus, says Cleveland Research
Cleveland Research Bryan Merolla's research indicates CSX's new network strategy on merchandise trains versus unit trains is causing near-term disruptions and confusion as customer adjust. Merolla is modeling Q2 revenues of +2.6% year-over-year versus consensus of up 6.7% and earnings of 56c versus consensus of 59c.
05/18/17
DBAB
05/18/17
NO CHANGE
DBAB
Buy
CSX CEO health concerns likely overstated, says Deutsche Bank
Deutsche Bank analyst Amit Mehrotra believes any health-related developments relating to Hunter Harrison are critical for CSX given the CEO's status as a change-agent for the company. The analyst, however, feels concerns following last night's Wall Street Journal are likely overstated. The report's mention of Harrison's limited sightings at CSX headquarters is "largely irrelevant," Mehrotra tells investors in a research note. Further, the analyst says use of an "over-the-shoulder oxygen system" is not nearly enough information to draw any conclusions. Mehrotra has a Buy rating on CSX shares.
06/06/17
BOFA
06/06/17
NO CHANGE
BOFA
CSX new CEO 'fully engaged,' says BofA/Merrill
BofA/Merrill analyst Ken Hoexter notes that CSX approved the compensation package of its new CEO, Hunter Harrison. The analyst says that Harrison promised "significant improvements in service, a focus on cost controls, and an intense focus on asset utilization." The CEO fielded multiple questions about his health and said his doctor had cleared him to work, Hoexter reported. .Hoexter raised his price target on the stock to $65 from $56 after moving to 2018 estimates for the name. He reiterates a Buy rating on the shares.
07/07/17
SBSH
07/07/17
NO CHANGE
SBSH
Citi names KSU top pick in Rails, removes Union Pacific from Focus List
Citi analyst Christian Wetherbee removed Union Pacific (UNP) from his firm's Focus List after resetting his preference list among the Railroads. The second half of 2017 "looks to be more of a grind for the group compared to the relatively smooth sailing" in the first half, Wetherbee tells investors in a research note. He names Kansas City Southern (KSU) his top pick in the sector, followed by Canadian Pacific (CP) and CSX (CSX). KSU's volume and revenue growth should stand out as it has more energy price neutral volume growth opportunities and its comps increase less than peers, the analyst contends.
BRK.A Berkshire Hathaway

03/20/17
03/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Monness Crespi analyst James Cakmak initiated Snap (SNAP) with a Buy and a $25 price target. 2. Workday (WDAY) initiated with a Buy at BofA/Merrill. 3. Berkshire Hathaway (BRK.A) initiated with an Equal Weight at Morgan Stanley. 4. MeetMe (MEET) initiated with a Buy at Canaccord. 5. ARC Document (ARC) resumed with a Buy at B. Riley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/17
MSCO
05/16/17
NO CHANGE
Target $212
MSCO
Overweight
IBM at attractive entry point ahead of mainframe cycle, says Morgan Stanley
Morgan Stanley analyst Katy Huberty attributes recent weakness in shares of IBM (IBM) to the combination of the news that Warren Buffett's Berkshire Hathaway (BRK.A) cut its stake by a third and the company's weak Q1 gross margin trends. However, growth accelerates and margins expand historically for IBM around a mainframe cycle, making the pullback an attractive entry point, according to Huberty. The analyst, who sees a number of the gross margin pressures that have recently plagued IBM abating in the second half of 2017, has a $212 price target on Big Blue's shares.
06/27/17
06/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Impinj (PI) was downgraded to Sector Weight from Overweight by Pacific Crest analyst Brad Erickson based on valuation. 2. Mizuho analyst Haendel St. Juste downgraded Store Capital (STOR) to Neutral from Buy citing fair valuation following recent strength driven by Berkshire Hathaway's (BRK.A) investment. 3. Camtek (CAMT) was downgraded to Hold from Buy by Needham analyst Y. Edwin Mok, as he expects to see some deceleration as the PCB business normalizes and he believes large orders for back-end semi inspections are already reflected in the stock after its recent run-up. 4. Nomura Instinet analyst Dan Dolev downgraded Cintas (CTAS) to Neutral from Buy after lowering his FY18 uniform rental organic growth forecasts to 5% from 7%. 5. Atlantic Equities analyst Barry MacCarthy downgraded Hess Corp. (HES) and Schlumberger (SLB), both to Neutral from Overweight, given his view of the limited prospects for an oil price rebound. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/17
LOOP
07/12/17
NO CHANGE
Target $42
LOOP
Buy
Core-Mark unlikely to 'get Amazoned,' says Loop Capital
Loop Capital analyst Andrew Wolf said he sees Core-Mark (CORE) as the least likely company among those he covers to get "Amazoned," or put at risk by Amazon (AMZN) buying a competitor. Its closest competitor McLane, which is owned by Berkshire Hathaway (BRK.B), is highly unlikely to sell to Amazon given that its largest customer is Amazon's rival Wal-Mart (WMT), Wolf tells investors. He keeps a Buy rating on Core-Mark and raised his target on the shares to $42 from $40 citing his increased 2018 EPS forecast.
KSU Kansas City Southern

03/15/17
WOLF
03/15/17
NO CHANGE
WOLF
Wolfe cuts Railroads to Market Weight, downgrades Norfolk Southern
Wolfe Research analyst Scott Group downgraded the Railroad sector to Market Weight from Overweight saying the risk/reward profiles are more balanced following the recent expansion of valuations. Group coupled the sector cut with a downgrade of Norfolk Southern (NSC) to Peer Perform from Outperform. The analyst thinks the company's operating ratio improvement could disappoint relative to CSX (CSX). He believes CSX has the best earnings story in the space under CEO Hunter Harrison.
06/16/17
FBCO
06/16/17
UPGRADE
Target $116
FBCO
Outperform
Kansas City Southern upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Allison Landry upgraded Kansas City Southern to Outperform and raised her price target for the shares to $116 from $90. After investor meetings with management, the analyst has increased confidence that the secular growth story at the company has re-emerged. Kansas City's growth opportunity in the cross border refined products business is "significantly larger" than expected, Landry tells investors in a research note. The analyst sees a "number of positives" that can drive "material upward revisions" to consensus estimates over the near- and mid-term.
06/19/17
AGIS
06/19/17
NO CHANGE
Target $115
AGIS
Buy
Kansas City Southern price target to $115 on volume growth at Aegis
Aegis analyst Jeffrey Kauffman raised Kansas City Southern estimates to reflect stronger then expected operations and increased its price target $115 from $110 to reflect managements improved business outlook. The analyst believes Kansas City's long-term growth opportunities will outpace other railroads and drive a premium growth multiple in time. Kauffman rates Kansas City Southern shares a Buy.
NSC Norfolk Southern
$122.59

-0.69 (-0.56%)

07/06/17
SCOT
07/06/17
DOWNGRADE
SCOT
Sector Perform
Norfolk Southern downgraded to Sector Perform from Outperform at Scotiabank
07/06/17
07/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Exxon Mobil (XOM) downgraded to Sector Perform from Outperform at RBC Capital with analyst Biraj Borkhataria saying Exxon's differentiated downstream positioning generates a significant portion of its free cash flow, but it is reflected in valuation. 2. O'Reilly Automotive (ORLY) downgraded to Neutral from Outperform at Credit Suisse and to Equal Weight from Overweight at Morgan Stanley. 3. Norfolk Southern (NSC) downgraded to Sector Perform from Outperform at Scotiabank. 4. Yum China (YUMC) downgraded to Hold from Buy at Deutsche Bank with analyst Anne Ling citing the company's second quarter results. 5. Tahoe Resources (TAHO) downgraded to Market Perform from Outperform at BMO Capital and to Hold from Buy at TD Securities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/17
OPCO
07/10/17
NO CHANGE
OPCO
Oppenheimer recommends buying American Airlines, United Continental
Oppenheimer analyst Ari Wald continues to make the case that interest rates are bottoming, reflationary sectors are positioned for a stronger second half, and market internals should strengthen as well. The analyst sees additional upside for both Banks and Transports, and within the last, its high-conviction idea is to keep buying airlines, such as Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), and United Continental (UAL). Elsewhere in Transports, Wald is bullish on the breakout in shares of FedEx (FDX) and Old Dominion (ODFL), and views Norfolk Southern (NSC) and Landstar System (LSTR) as attractive pre-breakout candidates.
07/13/17
FBCO
07/13/17
NO CHANGE
Target $139
FBCO
Outperform
Norfolk Southern price target raised to $139 from $133 at Credit Suisse
Credit Suisse analyst Allison Landry raised her price target for Norfolk Southern to $139 from $133 on valuation. The analyst reiterates an Outperform rating on the shares.
UNP Union Pacific
$108.85

-0.36 (-0.33%)

03/14/17
WELS
03/14/17
INITIATION
WELS
Market Perform
Union Pacific initiated at Wells Fargo
As noted earlier, Wells Fargo started coverage of Union Pacific with a Market Perform rating. The firm says that the company's coal business is "more defensible" than those of its competitors, while it should benefit from "secular gains in intermodal." However,. Wells adds that its "superior operations" will make it difficult for the company to realize further margin gains and return improvements. It thinks that the company's EPS and free cash flow gains will lag those of its peers. Target $105-$115.
05/23/17
JPMS
05/23/17
INITIATION
Target $37
JPMS
Neutral
Hub Group initiated with a Neutral at JPMorgan
JPMorgan analyst Brian Ossenbeck started Hub Group (HUBG) with a Neutral rating and $37 price target. The company's intermodal volumes should lag the market since its largest railroad partner, Union Pacific (UNP), is losing share to BNSF and the Panama Canal, the analyst tells investors.

TODAY'S FREE FLY STORIES

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

CZR

Caesars

$12.20

0.15 (1.24%)

09:45
10/21/17
10/21
09:45
10/21/17
09:45
Periodicals
Caesars looks ready to grow again, Barron's says »

After a disastrous 2008…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

DWDP

DowDuPont

$71.18

0.29 (0.41%)

09:40
10/21/17
10/21
09:40
10/21/17
09:40
Periodicals
DowDuPont shares likely to return as much as 30% over next year, Barron's says »

If DowDuPont can cut $3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

0.88 (2.23%)

09:29
10/21/17
10/21
09:29
10/21/17
09:29
Periodicals
Coach shares look undervalued, could rise nearly 30%, Barron's says »

Coach, which has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$96.50

1.8 (1.90%)

, MOH

Molina Healthcare

$64.40

0.76 (1.19%)

09:24
10/21/17
10/21
09:24
10/21/17
09:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$96.50

1.8 (1.90%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

AET

Aetna

$160.84

3.2 (2.03%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

CYH

Community Health

$6.44

0.24 (3.87%)

HCA

HCA Healthcare

$81.05

1.26 (1.58%)

LPNT

LifePoint

$58.35

0.5 (0.86%)

THC

Tenet

$14.66

1.31 (9.81%)

UHS

Universal Health

$112.85

2.31 (2.09%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

FB

Facebook

$174.98

0.42 (0.24%)

INTC

Intel

$40.43

0.34 (0.85%)

IBM

IBM

$162.07

1.17 (0.73%)

MAR

Marriott

$115.02

-0.18 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 29

    Nov

  • 30

    Nov

  • 18

    Mar

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

08:55
10/21/17
10/21
08:55
10/21/17
08:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

08:45
10/21/17
10/21
08:45
10/21/17
08:45
General news
Breaking General news story  »

New York Federal Reserve…

FB

Facebook

$174.98

0.42 (0.24%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

08:25
10/21/17
10/21
08:25
10/21/17
08:25
Periodicals
Regulators inquiries fuel speculation about big tech breakup, Barron's says »

Facebook (FB), Amazon…

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

07:58
10/21/17
10/21
07:58
10/21/17
07:58
Hot Stocks
DBV believes FDA suggested continue moving forward with Viaskin »

DBV Technologies (DBVT)…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

04:55
10/21/17
10/21
04:55
10/21/17
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

04:55
10/21/17
10/21
04:55
10/21/17
04:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.